Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Bioorganic Chemistry|March 24, 2022
Targeting the HVEM protein using a fragment of glycoprotein D to inhibit formation of the BTLA/HVEM complexKatarzyna Kuncewicz, Claire Battin, Katarzyna Węgrzyn, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2021
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation programJavier Arranz-Nicolás, Miguel Martin-Salgado, Irene Adán-Barrientos, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 20, 2023
BTLA-derived peptides as inhibitors of BTLA/HVEM complex formation - design, synthesis and biological evaluationKatarzyna Kuncewicz, Magdalena Bojko, Claire Battin, et al.
Scientific Reports|August 9, 2019
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signalingAnnika De Sousa Linhares, Claire Battin, Sabrina Jutz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2003
B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergyNicole Selenko-Gebauer, Otto Majdic, Andreas Szekeres, et al.
Nature Communications|November 28, 2023
Interrogating ligand-receptor interactions using highly sensitive cellular biosensorsMaximilian A Funk, Judith Leitner, Marlene C Gerner, et al.
The Journal of Allergy and Clinical Immunology|January 8, 2011
Bet v 1-specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1-specific T-cell effector function in an activation-dependent mannerKlaus G Schmetterer, Daniela Haiderer, Victoria M Leb-Reichl, et al.
The FEBS Journal|May 10, 2020
Attenuation of canonical NF-κB signaling maintains function and stability of human TregLiesa S Ziegler, Marlene C Gerner, Ralf L J Schmidt, et al.
Pageof 14